Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab. Rabinovici GD. N Engl J Med 2021 Jul 28. doi: 10.1056/NEJMp2111320.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rabinovici GD. Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab. N Engl J Med 2021 Jul 28. doi: 10.1056/NEJMp2111320.
PMID: 34320284